TOBI Adverse Event: Infective pulmonary exacerbation of cystic fibrosis
TOBI Adverse Event: Infective pulmonary exacerbation of cystic fibrosis is one of 4,500 adverse events in the FDATracker dataset. Key details — Primary drug: TOBI; Product category: Drug; Primary reaction: Infective pulmonary exacerbation of cystic fibrosis.
| Primary drug | TOBI |
|---|---|
| Product category | Drug |
| Primary reaction | Infective pulmonary exacerbation of cystic fibrosis |
| All reactions | Infective pulmonary exacerbation of cystic fibrosis |
| Seriousness | Serious |
| Patient outcome | Not Recovered/Not Resolved |
| Patient sex | Male |
| All drugs reported | TOBI; TOBI; TOBI PODHALER; TOBI PODHALER |
| Reporter country | US |
| Reporter type | 1 |
| Report date | 20140312 |
| Report ID | 10005272 |
$299/mo
Try FDATracker →